We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Benchtop Technology Designed for Marking, Selecting Cells

By LabMedica International staff writers
Posted on 22 Jan 2013
Print article
Image: The most common jellyfish protein used in lab research glows green when illuminated with UV light (Photo courtesy of NA/TSRI).
Image: The most common jellyfish protein used in lab research glows green when illuminated with UV light (Photo courtesy of NA/TSRI).
Chemists have found a simpler way to perform one of the most essential chores in molecular biology. Their new method allows scientists to add a marker to specific cells, so that these cells may be easily located and/or chosen from a larger cell population.

The technique, which is described in January 2012 in the chemistry journal Angewandte Chemie International Edition, makes use of the tight binding of two proteins that are inexpensively available but are not found in human or other mammalian cells. Therefore, it has advantages over existing cell-marking techniques.

“This new technique is cheap, easy, and sensitive,” said the Scripps Research Institute (TSRI; La Jolla, CA, USA) Prof. Richard A. Lerner, who is the senior author of the new report. “The method should be useful in a variety of applications that require separating out certain types of cells.”

The best-known cell marker currently used is green fluorescent protein (GFP), a protein derived from a jellyfish that emits a characteristic green light when illuminated by specific light wavelengths. When scientists need to add a new gene to cells, for example, to produce a therapeutic protein, they frequently construct a genetic sequence that also includes the GFP gene. Consequently, the cells that effectively produce the new protein will also generate GFP, whose fluorescence allows these cells to be identified and even sorted out from a larger population.

However, fluorescence-based cell sorting is comparatively costly and cumbersome. Alternative cell-marking techniques use marker molecules to which metals or antibodies will bind tightly, but these tend to have annoying side effects on the cells that they mark. Prof. Lerner’s team, led by first author Yingjie Peng, a postdoctoral fellow, set out to devise a better approach.

The new method exploits a special characteristic of chitinase enzymes, which evolved degrade chitin—a rugged, sugar-derived substance found, for example, in squid beaks, crab shells, and the cell walls of fungi. In addition to a main chitin-breaking domain, chitinases have another active structure, a chitin-binding domain (ChBD). “It makes a super-strong bond with chitin,” said Dr. Peng. Recently, scientists have begun to use this high-affinity binding of ChBD and chitin as a marker system, typically for selecting ChBD-tagged proteins in a lab dish. The new method uses ChBD to mark and select cells.

A new gene, in the method, can be added to cells within a larger DNA vector that also includes the genetic sequences for ChBD and GFP. The ChBD molecule will be produced in such a way that it ends up being held on the outer surface of its host cell’s plasma membrane—and the GFP molecule will sit just inside the membrane. The GFP acts as a visual beacon, while the ChBD serves as a handy gripping point for cell selection.

The scientists, after exposing a culture of test cells to this research ChBD-containing vector, were able to visualize, by way of the GFP tags, which cells were expressing them, and was able to pick them out easily, with high sensitivity, utilizing magnetic beads coated with chitin. “This is a relatively easy benchtop method,” Dr. Peng said. Significantly, these selected cells could generate progeny cells that appeared healthy.

Because the ChBD marker, in the vector, is produced in a manner that secures it to a cell’s membrane, it also can serve as a vital application for selecting just the membrane fraction of a sample of cellular material. Dr. Peng and his colleagues showed this using chitin beads to rapidly isolate a pure fraction of membrane material from ChBD-marked test cells. Cellulase enzymes, which degrade the common plant compound cellulose, also have a high-affinity cellulase-binding domain, which can be employed in the same way as the ChBD.

The scientists expect that the new cell-marking method will help to streamline another major molecular biology technique, which was developed by the Lerner laboratory in parallel with the group of Sir Gregory Winter at the Laboratory of Molecular Biology (Cambridge, UK). This technique allows scientists to produce very large and diverse libraries of antibody arms, and to sift through them, or “pan”—in the way miners pan for gold nuggets—for those that might be of use, for example in therapies. ChBD-based markers should be beneficial in boosting the effectiveness of this panning process, according to Dr. Peng.

The investigators are also assessing the potential use of ChBD-based cell marking in living animals, for example, to monitor the outcome of selected cell types throughout an animal’s lifecycle.

Related Links:
Scripps Research Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: Molecular PCR-grade detection of Lyme bacteria right at the tick bite (Photo courtesy of En Carta Diagnostics)

Groundbreaking Molecular Diagnostic Kit to Provide Lyme Disease Detection in Minutes

Lyme disease, transmitted through tick bites, is a bacteria-caused illness that impacts 1.2 million individuals annually. The standard methods for diagnosing this disease include clinical examinations,... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

Multiple sclerosis (MS) is a chronic neurological condition for which there is currently no cure. It affects around three million people globally and ranks as the second most common cause of disability... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: Insulin proteins clumping together (Photo courtesy of Jacob Kæstel-Hansen)

AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more